ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $256,858,415 | -15.2% | 9,464,201 | -3.9% | 1.04% | -16.0% |
| Q2 2023 | $302,817,650 | -25.0% | 9,850,932 | -12.1% | 1.24% | -34.6% |
| Q1 2023 | $403,689,091 | +2.1% | 11,204,249 | +11.9% | 1.90% | -4.3% |
| Q4 2022 | $395,536,355 | -9.5% | 10,008,511 | -8.0% | 1.98% | -1.9% |
| Q3 2022 | $437,222,000 | -15.9% | 10,881,594 | -12.0% | 2.02% | -15.1% |
| Q2 2022 | $520,064,000 | +24.0% | 12,370,694 | +14.9% | 2.38% | +40.3% |
| Q1 2022 | $419,384,000 | +2.0% | 10,764,472 | +4.4% | 1.70% | +43.2% |
| Q4 2021 | $411,068,000 | +174.7% | 10,315,378 | +149.1% | 1.18% | +188.8% |
| Q3 2021 | $149,638,000 | +12.7% | 4,140,508 | +27.8% | 0.41% | +2.0% |
| Q2 2021 | $132,752,000 | +47.6% | 3,238,654 | +57.1% | 0.40% | +50.0% |
| Q1 2021 | $89,934,000 | -21.4% | 2,061,753 | -9.8% | 0.27% | -14.9% |
| Q4 2020 | $114,464,000 | +39.7% | 2,287,000 | +17.4% | 0.32% | +6.4% |
| Q3 2020 | $81,955,000 | -32.9% | 1,948,064 | -22.5% | 0.30% | -43.9% |
| Q2 2020 | $122,103,000 | – | 2,514,985 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |